Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024530 (
malaria
)
44,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Despite the launching of many efforts against
malaria
over the past decade, the disease remains problematic. In some places the disease is getting worse, and in others it is being held in check, but nowhere are the incidence and prevalence of
malaria
being reduced. This failure to reduce the burden of
malaria
is due to the
lack of coordination
of international assistance to countries for control efforts, failure to deliver and implement
malaria
control tools due to weak health systems in
malaria
-endemic countries, inadequate funding, and technical reasons such as drug and insecticide resistance. The World Health Organization's (WHO) Roll Back
Malaria
(RBM) project is addressing all of these issues. The RBM aims to coordinate global action to fight
malaria
and help governments reach their own targets to combat the disease in their countries. To help countries and monitor all interventions, RBM will depend upon resource networks, each concerned with a specific issue and linking experts in research and academic institutions with district health teams and disease control institutions in endemic countries. Already functioning for 6 months, the RBM's first priority was Africa. The RBM is now expanding to other regions, and preparations are being made in the WHO regional offices for southeast Asia and the western Pacific.
...
PMID:Rolling back malaria. 1232 20